Dr. Bartlett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
660 S Euclid Ave
Saint Louis, MO 63110
Education & Training
Washington University in St. Louis School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1988 - Present
MO State Medical License 1993 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Autologous Stem Cell Transplant-Eligible Patients With Relapsed/Refractory Aggressive B Cell Lymphoma Start of enrollment: 2023 Jan 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 17 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis
Journal of the National Comprehensive Cancer Network. 2023-11-01 - 6 citationsMutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P Watkins
Blood Advances. 2023-09-26 - 7 citationsCell-of-origin effect of polatuzumab vedotin in diffuse large B-cell lymphoma: no ordinary subgroup analysis.David A Russler-Germain, Edward R Scheffer Cliff, Nancy L Bartlett
Blood. 2023-12-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
